Renal IRI is a leading cause of AKI in several disease states; currently there are several methods to measure renal perfusion in the clinic, but all suffer under specific drawbacks. Here we present a pilot study using the hyperpolarized perfusion marker α-trideuteromethyl[15N]glutamine in a 40 min unilateral ischemia reperfusion rat model. A reduction of 51% in perfusion was observed in the animal. We therefore believe that α-trideuteromethyl[15N]glutamine is a highly promising molecule in renal perfusion studies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords